MetaCap

MaxCyte Statistics

NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD

1.37+0.09 (+7.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MaxCyte by the numbers

MaxCyte has a market capitalization of $141.5 million based on 103.25M shares outstanding. With trailing EPS of $-0.26, MaxCyte is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.2% above its 50-day average and 27.0% above its 200-day average.

Average daily trading volume is 1.04M shares, or about $1.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MXCT valuation vs. peer median

MXCT compared with the median of 8 peer companies
MetricMXCTPeer medianDifference
Market cap$141.45M$606.82M-77%
Avg. volume1.04M1.01M+3%

Peer median across 8 companies: ONMD, BIAF, ISPC, NRC, OABI, ABSI, ICLR, CRL.

Valuation

Market cap
$141.45M
Price / sales (latest FY)
4.28
EPS (TTM)
$-0.26

Price and trading

Previous close
1.28
Open
1.29
Day range
1.27 – 1.42
52-week range
0.643 – 1.80
52-week change
-17.96%
Beta
—
Volume
1.11M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
141.45M
Forward Pe
-5.96
Eps
-0.26
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.80
Week52 Low
0.64
Avg Volume
1.04M
Shares Outstanding
103.25M
Ma50
1.25
Ma200
1.08
Earnings Date
Nov 10, 2026
Pct From52w High
-23.89%
Pct From52w Low
113.06%

Related